EVIO, Inc. EVIO Archives - Page 2 of 6

FridayJun 22, 2018 1:38 pm

EVIO Inc. (EVIO) Appoints New Board Member, Aims to Strengthen Biosciences Division

New appointment expected to strengthen EVIO’s Biosciences division Licensed cannabis sales expected to reach $21 billion by 2021 due to industry strengthening and legislative changes U.S. administration signals shift on cannabis legalization, considers leaving leave the decision with each state A leading provider of testing services for the regulated cannabis industry, EVIO Inc. (OTCQB: EVIO) announced the appointment of a new member to its board of directors on June 19, 2018. Felipe Campusano has joined the EVIO board as an independent director. Campusano has extensive experience in operating Canadian pharmacies, which could prove to be invaluable for the EVIO business…

WednesdayJun 20, 2018 9:30 am

QualityStocksNewsBreaks – EVIO, Inc. (EVIO) Preparing for Increased Demand as California’s July 1 Testing Deadline Approaches

EVIO, Inc. (OTCQB: EVIO), a leading provider of cannabis testing and scientific research for the regulated cannabis industry, this morning detailed its recent expansion to meet increased cannabis testing demand following California’s July 1 testing deadline. The regulations set forth by California's Bureau of Cannabis Control state that, beginning July 1, a licensed retailer may only sell cannabis goods that have met all state-mandated testing requirements. Among EVIO’s efforts, the company’s EVIO Labs Berkeley facility is in the process of becoming ISO 17025 accredited – the highest recognized quality standard in the world for calibration and testing laboratories. “The new…

ThursdayJun 14, 2018 10:33 am

QualityStocksNewsBreaks – EVIO, Inc. (EVIO) Expands into Canadian Cannabis Market

EVIO’s (OTCQB: EVIO) Canadian subsidiary, EVIO Canada, recently finalized a 50% acquisition of Keystone Labs, Inc., a Health Canada-licensed medical cannabis testing facility. An article discussing the company reads: “EVIO Inc. (OTCQB: EVIO) reached a significant milestone in its expansion plans in early May when its new subsidiary, EVIO Canada, announced its acquisition of a 50 percent stake in Keystone Labs, Inc., a licensed Canadian testing laboratory specializing in quality testing for regulated industries such as cannabis. In a May 3, 2018, news release announcing the deal (http://ibn.fm/U6rN2), William Waldrop, CEO and co-founder of EVIO, said Keystone Labs fits perfectly…

FridayJun 08, 2018 1:40 pm

QualityStocksNewsBreaks – EVIO, Inc. (EVIO) Increases Testing Capacity through Acquisition

EVIO, Inc. (OTCQB: EVIO), a leading provider of cannabis testing and scientific research for the regulated cannabis industry, recently executed an asset purchase agreement to acquire 100 percent of Leaf Detective, LLC, a California-based testing laboratory. An article discussing the company reads: “In terms of the agreement, EVIO will form a new entity, EVIO Labs Humboldt, to purchase all of Leaf Detective’s business assets for a total consideration of $500,000 in the form of a Convertible Promissory Note, which is convertible at $1.25 per share. The purchase includes brand, customer lists and contracts, rental agreements, equipment and equipment leases. ……

TuesdayJun 05, 2018 12:11 pm

EVIO Inc. (EVIO) Expanding into Biosciences with a Focus on Cannabis and Cannabinoid Research

EVIO Biosciences Division will research and develop new medical cannabis therapies New division will be headed by the company’s chief science officer, Dr. Anthony Smith EVIO CEO and co-founder to present at key microcap investor conference As an established leader in cannabis testing in the United States and Canada, EVIO Inc. (OTCQB: EVIO) is more familiar than most with the knowns and unknowns of medical cannabis. The company is now maximizing its technical know-how and experience by expanding into the research and development of cannabis-based medicines. In a press release issued on May 24, EVIO unveiled the launch of its…

MondayJun 04, 2018 11:48 am

EVIO Inc. (EVIO) Expands Footprint to Los Angeles

Demand for accredited cannabis testing in California is at an all-time high Company enters long-term lease in the heart of Los Angeles Strategically positioned to capitalize on the largest market place in the United States State mandated testing for California’s cannabis industry will allow only lab-tested cannabis products to be sold by licensed retailers beginning on July 1. There is a high probability that there won’t be enough labs in California to keep up with the testing requirements. This is positive news for existing labs, as demand will be high and possibly max out their capacity, creating a surge in…

ThursdayMay 31, 2018 11:18 am

QualityStocksNewsBreaks – EVIO, Inc. (EVIO) Chief Science Officer Scheduled to Present at CannaWest Compliance, Testing & Product Safety Summit

EVIO, Inc. (OTCQB: EVIO), a leading provider of cannabis testing and scientific research for the regulated cannabis industry, today announced that Dr. Anthony Smith, its chief science officer, will be presenting at the CannaWest Compliance, Testing & Product Safety Summit taking place from June 5-7 at the Crowne Plaza Redondo Beach & Marina Hotel in Los Angeles. Per the update, Smith’s presentation, titled ‘Cannabinoid Chromatography: Precision, Accuracy and the Industrialization of Potency Analysis’, will focus on the evolution of cannabinoid potency measurement and the power of data to provide insight into the intrinsic and extrinsic variability in cannabinoid measurements within…

ThursdayMay 24, 2018 10:38 am

QualityStocksNewsBreaks – EVIO, Inc. (EVIO) Announces Launch of EVIO Biosciences Division

EVIO, Inc. (OTCQB: EVIO), a leading provider of cannabis testing and scientific research for the regulated cannabis industry, this morning announced the launch of its EVIO Biosciences Division. Per the update, the new division, which will be led by Dr. Anthony Smith, chief science officer of EVIO, will allow the company to leverage its scientific and human capital expertise to focus on the development of intellectual property and research. The division’s goals encompass emerging health benefits and advanced delivery modes for cannabinoids and cannabis products targeting the human endocannabinoid system. “We are expanding the life sciences part of the company…

TuesdayMay 22, 2018 9:28 am

QualityStocksNewsBreaks – EVIO, Inc. (EVIO) Inks Lease Agreement for Cannabis Testing Facility in LA

EVIO, Inc. (OTCQB: EVIO), a leading provider of cannabis testing and scientific research for the regulated cannabis industry, recently announced that it has expanded into the Southern California cannabis market through the execution of a long-term lease for a 2,700 square foot facility in Los Angeles. The facility will enable the company to provide its accredited analytical testing services to another area where licensed retailers are required to only sell lab tested products, following the July 1, 2018 mandated testing deadline in California. Completion of the Los Angeles facility is anticipated by Fall 2018. "This is the next step in…

FridayMay 18, 2018 2:33 pm

EVIO, Inc. (EVIO) CEO Discusses Growing Need for Reliable Cannabis Testing, Industry Investment Opportunities at The MoneyShow Las Vegas

CEO and co-founder William Waldrop attended several events, detailed his company’s operations and growth plans in the context of a rapidly expanding cannabis market with its associated auxiliary services Special Cannabis Investing Event was included in The MoneyShow Las Vegas schedule, with prominent industry speakers in attendance Topics of discussion revolved around medical and recreational marijuana, ancillary services, investment opportunities, leading companies and more The rapid expansion of the cannabis industry over the last couple of years took center stage at The MoneyShow Las Vegas on May 14-16, with multiple workshops, meetings and panels organized as part of a special…

Site Search

Company Search

Tag: EVIO, Inc. EVIO